共 67 条
[1]
Ang KK(2014)Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522 Journal of clinical oncology: official journal of the American Society of Clinical Oncology 32 2940-2950
[2]
Nguyen-Tan PF(2014)Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity J Clin Oncol 32 3858-3866
[3]
Masood R(2006)EphB4 provides survival advantage to squamous cell carcinoma of the head and neck International journal of cancer. Journal international du cancer 119 1236-1248
[4]
Pasquale EB(2005)Eph receptor signalling casts a wide net on cell behaviour Nat Rev Mol Cell Biol 6 462-475
[5]
Noren NK(2007)Paradoxes of the EphB4 receptor in cancer Cancer Res 67 3994-3997
[6]
Pasquale EB(2013)The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target PloS one 8 e67668-4632
[7]
Ferguson BD(2005)EphB4 expression and biological significance in prostate cancer Cancer Res 65 4623-293
[8]
Xia G(2006)Receptor tyrosine kinase EphB4 is a survival factor in breast cancer Am J Pathol 169 279-4315
[9]
Kumar SR(2005)Up-regulation of EphB4 in mesothelioma and its biological significance Clin Cancer Res 11 4305-194
[10]
Xia G(2013)Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers Cancer research 73 184-2498